Suppr超能文献

抗结核化疗治疗结核性淋巴结炎患者淋巴结消退的决定因素:一项基于医院的纵向研究。

Determinants of lymph node resolution in patients of tubercular lymphadenitis treated with anti tuberculous chemotherapy: A hospital based longitudinal study.

机构信息

Pulmonary Medicine, AIIMS Bhopal, India.

Otorhinolaryngology & Head and Neck Surgery, AIIMS Bhopal, India.

出版信息

Indian J Tuberc. 2021 Apr;68(2):215-220. doi: 10.1016/j.ijtb.2020.08.009. Epub 2020 Aug 26.

Abstract

INTRODUCTION

The variable course of illness in patients of Tubercular lymphadenitis remains a therapeutic challenge to treating physicians in a significant proportion of patients. This study was aimed to explore the possible determinants which could predict the outcome of this subgroup of patients.

METHODOLOGY

This was a prospective cohort study where 94 patients of TB lymphadenitis were enrolled who could be followed up till the end of treatment. They were evaluated in the beginning and monitored till the end of treatment keeping into account the clinical behaviour of lymph nodes during the course of Anti tubercular chemotherapy.

RESULTS

Out of 94 patients, 60 had their lymph nodes resolved at the end of prescribed treatment duration wheras 34 were classified as partial responders. Another 26 amongst them had their nodes resolved by an extension of continuation phase by 3-6 months. Presence of bilateral and multiple lymph nodes, necrosis on Fine needle aspiration at initial diagnosis and occurrence of Paradoxical upgrading reaction were associated with the partial resolution of lymph nodes at the end of stipulated ATT duration.

CONCLUSION

Treatment duration should be individualized by the treating physicians. Certain parameters mentioned above can be taken as warning signals of patients ending up as partial responders and hence the need of a prolonged extension phase.

摘要

简介

在相当一部分患者中,结核性淋巴结炎患者的疾病病程多变仍然是治疗医生面临的治疗挑战。本研究旨在探讨可能的预测因素,以预测这组患者的结局。

方法

这是一项前瞻性队列研究,共纳入 94 例可随访至治疗结束的结核性淋巴结炎患者。在开始时对他们进行评估,并在治疗过程中监测他们的临床淋巴结行为,直至治疗结束。

结果

94 例患者中,60 例在规定治疗时间结束时淋巴结消退,34 例为部分缓解者。其中另外 26 例通过延长 3-6 个月的巩固期来使淋巴结消退。初始诊断时存在双侧和多个淋巴结、细针抽吸活检有坏死以及出现矛盾性升级反应与规定 ATT 时间结束时淋巴结部分消退有关。

结论

治疗医生应根据个体情况确定治疗时间。上述某些参数可作为患者成为部分缓解者的预警信号,因此需要延长延伸期。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验